查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1371958

2030 年数位锭剂市场预测：按产品、适应症、疾病、目标领域、用途、最终用户和地区进行的全球分析

Digital Pills Market Forecasts to 2030 - Global Analysis By Product (Capsule, Tablet and Microchip Delivery Device), Indication, Disease, Target Area, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球数位锭剂电脑市场规模将达到 6 亿美元，预计在预测期内年复合成长率为 11.8%，到 2030 年将达到 17 亿美元。

数位锭剂是一种结合了药物管理和电子监控组件的医疗技术。也称为智慧药丸和可摄入感测器。旨在提高药物依从性、追踪摄取模式和监测生理资料。该锭剂包含一个由安全材料製成的小型可摄入感测器，通常由硅胶、铜和镁等元素结构。数位锭剂提供药物依从性、即时监测、客製化治疗计划、临床试验和研究。

根据美国成瘾中心的数据，2018 年，美国约有 300 万名 18 岁青少年患有思觉失调症。思觉失调症患病的上升预计将极大地推动数位医学领域的发展。

提高老年护理意识

养老服务与数位锭剂的结合可以改善老年人的健康和福祉，让他们安心地度过晚年。透过提供有关老年人用药依从性和健康结果的公正资料，数位锭剂可能成为医学研究和临床试验的重要组成部分。患有多种慢性病的长者经常给药多种药物治疗。使用数位锭剂管理复杂的处方方案、发送提醒和监控用药依从性，降低用药错误的风险。此外，看护者通知、持续监测和老年友善技术正在推动市场扩张。

严格法规

法规监督可确保数位锭剂有效实现其预期的医疗目的。法规首要关注的是确保任何医疗产品（包括数位锭剂）可供病人安全使用。严格的法规有助于防止引入潜在有害或危险的技术。数位锭剂必须经过彻底的法规审查，以确保其安全性和有效性。这种要求高且复杂的过程正在阻碍市场需求。

活性化研发活动

数位锭剂领域的研发 (R&D) 活动正在迅速增加。背后的原因是该技术有潜力彻底改变药物管理并改善患者的治疗结果。研究人员正在研究更复杂的感测器，可以准确检测锭剂何时被摄入。客製化、使用者友善介面、无线通讯协定和数数位锭剂小型化的研究正在进一步加速市场成长。

患者可接受性和适用性有限

数位锭剂的患者接受度和适用性有限是由于隐私和安全问题、新颖性和不熟悉性、对技术故障或失败的恐惧以及有限的可用性和承受能力。患者接受数位药丸也存在心理障碍。此外，并非所有患者或医疗状况都可以从数位药丸中受益。所有这些要素都在抑制市场需求。

COVID-19 的影响

新冠大流行对数位药丸市场既有正面的影响，也有负面的影响。这场流行病扰乱了全球供应链，影响了数位药丸及其零件的生产和分销。此外，在封锁期间，获得医疗保健服务（包括数位医疗技术）仅限于某些人群。然而，由于对远端监控、慢性病管理的重视以及远端医疗的日益采用，该市场正在呈现获利成长。

思觉失调症患者的后续摄取量预计在预测期内是最大的

思觉失调症患者追踪摄取量预计将出现良好增长。一些思觉失调症患者面临着与其病情相关的耻辱。数位锭剂提供了一种不引人注目的方式来监测药物依从性，无需直接观察，有助于保护病患的自主权和隐私。它还提供个体化的治疗计划并追踪一段时间内的药物依从模式。早期疗育和降低復发风险正在推动这一领域的需求。

预计医院领域在预测期内复合年复合成长率最高。

由于对微创手术治疗的需求不断增长、药物依从性下降以及全球住院和手术数量不断增加，预计医院领域在预测期内将出现最高的年复合成长率。整体而言，发炎性肠道疾病(IBD) 患者的激增促使医院采用数位锭剂作为诊断程序中的宝贵工具。智慧药丸是非侵入性的，能够进行早期检测和诊断，这推动了该领域的需求。

比最大的地区

由于医疗保健意识的提高、技术的进步以及慢性病负担的增加，预计亚太地区将在预测期内占据最大的市场占有率。亚太地区许多国家正在增加医疗保健支出，以改善医疗保健基础设施、可近性和品质。世界各国政府正在实施政策和倡议，以加速数位医疗技术的采用。此外，人口高龄化的加剧、临床研究和医疗保健支出的增加正在推动该地区的市场成长。

复合年复合成长率最高的地区：

由于其强大的技术基础设施和高龄化，预计北美在预测期内将呈现最高的年复合成长率。北美在医疗保健研究和创新方面处于世界领先地位。该地区拥有众多正在推动数位健康进步的製药公司、技术公司和研究机构。心臟病、糖尿病和高血压等慢性病在北美很常见。定期的合作和伙伴关係以及持续的监控技术正在推动该地区的市场需求。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和年复合成长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

  • 概述
  • 利害关係人
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第3章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第5章全球数位药丸市场：按产品

  • 胶囊
  • 药片
  • 微晶片输送装置

第6章全球数位药丸市场：依迹象分类

  • 追踪思觉失调症患者的摄取状况
  • 追踪双极性情感障碍患者的摄取量
  • 重度忧郁症（MDD）

第7章全球数位药丸市场：依疾病分类

  • 癌症
  • 糖尿病
  • 循环系统疾病
  • 感染疾病
  • 精神障碍
  • 其他疾病

第8章全球数位药丸市场：按目标地区

  • 食道
  • 小肠
  • 冒号
  • 胃

第9章全球数位药丸市场：按应用

  • 胶囊内视镜
  • 靶向药物输送
  • 生命征象监测

第10章全球数位药丸市场：依最终用户分类

  • 医院
  • 诊断中心
  • 家庭护理设置
  • 其他最终用户

第11章全球数位药丸市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第12章进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第13章公司简介

  • Abbott Laboratories
  • Proteus Digital Health Inc.
  • Pure Tech
  • Medtronic
  • 2morrow Inc.
  • Gentag Inc.
  • AnX Robotica Corporation
  • CapsoVision Inc.
  • Teladoc Health Inc.
  • Microchips Biotech Inc.
  • Omada Health Inc
  • Otsuka Holdings Co Limited
  • Livongo Health
  • Novartis AG
  • Leaf Healthcare Inc
  • Perficient Inc
  • AliveCor Inc
  • WellDoc Inc
  • Mocacare
  • iRhythm Technologies Inc
Product Code: SMRC24015

According to Stratistics MRC, the Global Digital Pills Market is accounted for $0.6 billion in 2023 and is expected to reach $1.7 billion by 2030 growing at a CAGR of 11.8% during the forecast period. Digital pills are a type of medical technology that combines medication with electronic monitoring components. They are also known as smart pills or ingestible sensors. They are designed to improve medication adherence, track ingestion patterns, and monitor physiological data. It contains a tiny ingestible sensor made of safe materials, typically composed of elements like silicon, copper, and magnesium. Digital pills provide medication adherence, real-time monitoring, customized treatment plans, clinical trials and research.

According to the American Addiction Center, in the U.S., around of 3 million people aged 18 suffered from Schizophrenia in 2018. The rising prevalence of Schizophrenia is expected to provide a significant boost to the digital pills sector.

Market Dynamics:

Driver:

Rising awareness of geriatric care

The combination of geriatric care with the use of digital pills improves elderly people's health and well-being, enabling them to age in place with assurance and support. By offering unbiased data on medication adherence and health effects in senior people, digital pills can be a key component of geriatric research and clinical trials. A range of drugs are frequently administered to older people who have several chronic diseases. The risk of medication mistakes can be decreased by using digital pills to manage complicated prescription regimens by sending out reminders and monitoring adherence. Additionally, its notifications to care givers, ongoing surveillance, and age-friendly technology are boosting the market's expansion.

Restraint:

Strict regulations

Regulatory oversight ensures that digital pills are effective in achieving their intended medical purposes. The primary concern of regulatory bodies is to ensure that any medical product, including digital pills, is safe for patients to use. Rigorous regulations help prevent the introduction of potentially harmful or risky technologies. Digital pills need to undergo thorough regulatory scrutiny to provide assurance of their safety and effectiveness. This strict and complex process hampers the market demand.

Opportunity:

Mounting R&D activities

There has been a surge in research and development (R&D) activities in the field of digital pills. This is driven by the potential of this technology to revolutionize medication management and improve patient outcomes. Researchers are working on developing more sophisticated sensors that can accurately detect when a pill is ingested. The research trails for customizations, user friendly interfaces, Wireless Communication Protocols and Miniaturization of digital pills are further accelerating the market growth.

Threat:

Limited patient acceptance & applicability

Limited patient acceptance and applicability for digital pills can be attributed by concerns about privacy and security, novelty and unfamiliarity, fear of technology malfunctions or failures, limited accessibility and affordability and so on. Also, patients may experience psychological barriers for accepting digital pills. In addition, not all patients or medical conditions may benefit from or be suitable for digital pills. All these factors are impeding the market demand.

COVID-19 Impact

The covid pandemic had both positive and negative impacts on the digital pills market. The pandemic led to disruptions in global supply chains, which have affected the production and distribution of digital pills and their components. In addition, access to healthcare services including digital health technologies has been limited for certain populations during lockdowns. But, due to increased emphasis on remote monitoring, focus on chronic disease management and telemedicine adoption the market has witnessed beneficial growth.

The tracking ingestion in schizophrenia patients segment is expected to be the largest during the forecast period

The tracking ingestion in schizophrenia patients segment is estimated to have a lucrative growth. Some individuals with schizophrenia may face stigma related to their condition. Digital pills provide a discreet way to monitor adherence without the need for direct observation, which can help preserve patient autonomy and privacy. Also, it provides personalized treatment plans and tracks adherence patterns over time. Its early intervention and reducing relapse risk is fuelling the segment demand.

The hospitals segment is expected to have the highest CAGR during the forecast period

The hospitals segment is anticipated to witness the highest CAGR growth during the forecast period, due to the rising demand for minimally invasive surgical treatments, poor medication adherence, and an increase in hospitalisations and surgical operations worldwide. Overall, the surge in inflammatory bowel disease (IBD) cases has prompted hospitals to embrace digital pills as a valuable tool in diagnostic procedures. The non-invasive nature of smart pills, coupled with their ability to enhance early detection & diagnosis is boosting the segment demand.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to increasing healthcare awareness, technological advancements, and a rising burden of chronic diseases. Many countries in the Asia Pacific region have been increasing their healthcare spending to improve healthcare infrastructure, accessibility, and quality. Governments in various countries have been implementing policies and initiatives to promote the adoption of digital health technologies. Further, the growing aging population, clinical research & trials and rising healthcare expenditure are driving the market growth in this region.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, owing to its strong technological infrastructure and aging population. North America is a global leader in healthcare research and innovation. The region is home to numerous pharmaceutical companies, technology firms, and research institutions that drive advancements in digital health. Chronic diseases like heart disease, diabetes, and hypertension are prevalent in North America. The region's regular collaborations and partnerships along with continuous monitoring technologies is fuelling the market demand.

Key players in the market:

Some of the key players profiled in the Digital Pills Market include: Abbott Laboratories, Proteus Digital Health Inc., Pure Tech, Medtronic, 2morrow Inc., Gentag Inc., AnX Robotica Corporation, CapsoVision Inc., Teladoc Health Inc., Microchips Biotech Inc., Omada Health Inc, Otsuka Holdings Co Limited, Livongo Health, Novartis AG, Leaf Healthcare Inc, Perficient Inc, AliveCor Inc, WellDoc Inc, Mocacare and iRhythm Technologies Inc.

Key Developments:

In April 2023, Medtronic has announced the launch of MRI Care Pathway, a new system that can streamline the process of completing MRI scans for patients with Medtronic MRI compatible cardiac devices.

In February 2023, AnX Robotica Corp. (US) launched the NaviCam Small Bowel System in the US. The NaviCam SB System utilizes aspherical lens technology to reduce distortion and enhance the field of vision, a critical component in the diagnosis of small bowel disease.

Products Covered:

  • Capsule
  • Tablet
  • Microchip Delivery Device

Indications Covered:

  • Tracking Ingestion in Schizophrenia Patients
  • Tracking Ingestion in Biopolar Patients
  • Major Depressive Disorder (MDD)

Diseases Covered:

  • Cancer
  • Diabetes
  • Cardiovascular Disease
  • Infectious Diseases
  • Mental Disorders
  • Other Diseases

Target Areas Covered:

  • Esophagus
  • Small Intestine
  • Large Intestine
  • Stomach

Applications Covered:

  • Capsule Endoscopy
  • Targeted Drug Delivery
  • Vital Sign Monitoring

End Users Covered:

  • Hospitals
  • Diagnostic Centers
  • Home Care Settings
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Digital Pills Market, By Product

  • 5.1 Introduction
  • 5.2 Capsule
  • 5.3 Tablet
  • 5.4 Microchip Delivery Device

6 Global Digital Pills Market, By Indication

  • 6.1 Introduction
  • 6.2 Tracking Ingestion in Schizophrenia Patients
  • 6.3 Tracking Ingestion in Biopolar Patients
  • 6.4 Major Depressive Disorder (MDD)

7 Global Digital Pills Market, By Disease

  • 7.1 Introduction
  • 7.2 Cancer
  • 7.3 Diabetes
  • 7.4 Cardiovascular Disease
  • 7.5 Infectious Diseases
  • 7.6 Mental Disorders
  • 7.7 Other Diseases

8 Global Digital Pills Market, By Target Area

  • 8.1 Introduction
  • 8.2 Esophagus
  • 8.3 Small Intestine
  • 8.4 Large Intestine
  • 8.5 Stomach

9 Global Digital Pills Market, By Application

  • 9.1 Introduction
  • 9.2 Capsule Endoscopy
  • 9.3 Targeted Drug Delivery
  • 9.4 Vital Sign Monitoring

10 Global Digital Pills Market, By End User

  • 10.1 Introduction
  • 10.2 Hospitals
  • 10.3 Diagnostic Centers
  • 10.4 Home Care Settings
  • 10.5 Other End Users

11 Global Digital Pills Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Abbott Laboratories
  • 13.2 Proteus Digital Health Inc.
  • 13.3 Pure Tech
  • 13.4 Medtronic
  • 13.5 2morrow Inc.
  • 13.6 Gentag Inc.
  • 13.7 AnX Robotica Corporation
  • 13.8 CapsoVision Inc.
  • 13.9 Teladoc Health Inc.
  • 13.10 Microchips Biotech Inc.
  • 13.11 Omada Health Inc
  • 13.12 Otsuka Holdings Co Limited
  • 13.13 Livongo Health
  • 13.14 Novartis AG
  • 13.15 Leaf Healthcare Inc
  • 13.16 Perficient Inc
  • 13.17 AliveCor Inc
  • 13.18 WellDoc Inc
  • 13.19 Mocacare
  • 13.20 iRhythm Technologies Inc

List of Tables

  • Table 1 Global Digital Pills Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Digital Pills Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Digital Pills Market Outlook, By Capsule (2021-2030) ($MN)
  • Table 4 Global Digital Pills Market Outlook, By Tablet (2021-2030) ($MN)
  • Table 5 Global Digital Pills Market Outlook, By Microchip Delivery Device (2021-2030) ($MN)
  • Table 6 Global Digital Pills Market Outlook, By Indication (2021-2030) ($MN)
  • Table 7 Global Digital Pills Market Outlook, By Tracking Ingestion in Schizophrenia Patients (2021-2030) ($MN)
  • Table 8 Global Digital Pills Market Outlook, By Tracking Ingestion in Biopolar Patients (2021-2030) ($MN)
  • Table 9 Global Digital Pills Market Outlook, By Major Depressive Disorder (MDD) (2021-2030) ($MN)
  • Table 10 Global Digital Pills Market Outlook, By Disease (2021-2030) ($MN)
  • Table 11 Global Digital Pills Market Outlook, By Cancer (2021-2030) ($MN)
  • Table 12 Global Digital Pills Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 13 Global Digital Pills Market Outlook, By Cardiovascular Disease (2021-2030) ($MN)
  • Table 14 Global Digital Pills Market Outlook, By Infectious Diseases (2021-2030) ($MN)
  • Table 15 Global Digital Pills Market Outlook, By Mental Disorders (2021-2030) ($MN)
  • Table 16 Global Digital Pills Market Outlook, By Other Diseases (2021-2030) ($MN)
  • Table 17 Global Digital Pills Market Outlook, By Target Area (2021-2030) ($MN)
  • Table 18 Global Digital Pills Market Outlook, By Esophagus (2021-2030) ($MN)
  • Table 19 Global Digital Pills Market Outlook, By Small Intestine (2021-2030) ($MN)
  • Table 20 Global Digital Pills Market Outlook, By Large Intestine (2021-2030) ($MN)
  • Table 21 Global Digital Pills Market Outlook, By Stomach (2021-2030) ($MN)
  • Table 22 Global Digital Pills Market Outlook, By Application (2021-2030) ($MN)
  • Table 23 Global Digital Pills Market Outlook, By Capsule Endoscopy (2021-2030) ($MN)
  • Table 24 Global Digital Pills Market Outlook, By Targeted Drug Delivery (2021-2030) ($MN)
  • Table 25 Global Digital Pills Market Outlook, By Vital Sign Monitoring (2021-2030) ($MN)
  • Table 26 Global Digital Pills Market Outlook, By End User (2021-2030) ($MN)
  • Table 27 Global Digital Pills Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 28 Global Digital Pills Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 29 Global Digital Pills Market Outlook, By Home Care Settings (2021-2030) ($MN)
  • Table 30 Global Digital Pills Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.